Horowitz: The indefensible approval of Pfizer and Merck drugs compared to the snubbing of ivermectin

boudica.us

We already know that every drug the FDA has approved so far for inpatient treatment has an FDA “black box warning” for serious adverse events. At present, the only approved drugs in-patient are remdesivir, baricitinib, and tofacitinib. None of them have demonstrated any efficacy over a year of their use, and remdesivir is known to…

View original post 61 more words

This entry was posted in Uncategorized. Bookmark the permalink.

1 Response to Horowitz: The indefensible approval of Pfizer and Merck drugs compared to the snubbing of ivermectin

  1. Pingback: Horowitz: The indefensible approval of Pfizer and Merck drugs compared to the snubbing of ivermectin — Boudica BPI Weblog – Freedom Is Just Another Word…

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s